No headlines found.
SERA PROGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS
PRNewswire (Wed, 18-Mar 4:05 PM ET)
PRNewswire (Wed, 4-Mar 8:05 AM ET)
SERA PROGNOSTICS TO PRESENT AT TD COWEN 46th ANNUAL HEALTH CARE CONFERENCE
PRNewswire (Tue, 17-Feb 8:05 AM ET)
Landmark Study Finds PreTRM Blood Test Reduces Earliest Preterm Births and Newborn Complications
PRNewswire (Wed, 7-Jan 8:30 AM ET)
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
Sera Prognostics - Class A trades on the NASDAQ stock market under the symbol SERA.
As of March 26, 2026, SERA stock price declined to $1.97 with 9,083 million shares trading.
SERA has a beta of 1.87, meaning it tends to be more sensitive to market movements. SERA has a correlation of 0.06 to the broad based SPY ETF.
SERA has a market cap of $77.11 million. This is considered a Micro Cap stock.
Last quarter Sera Prognostics - Class A reported $10,000 in Revenue and -$.16 earnings per share. This fell short of revenue expectation by $-6,000 and exceeded earnings estimates by $.02.
In the last 3 years, SERA traded as high as $12.36 and as low as $1.37.
The top ETF exchange traded funds that SERA belongs to (by Net Assets): VTI, VXF, IWC, AVSC.
SERA has underperformed the market in the last year with a return of -51.4%, while the SPY ETF gained +13.7%. In the last 3 month period, SERA fell short of the market, returning -45.3%, while SPY returned -6.0%. However, in the most recent 2 weeks SERA has outperformed the stock market by returning +2.1%, while SPY returned -4.1%.
SERA support price is $1.80 and resistance is $2.18 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SERA shares will trade within this expected range on the day.
